MedPath

Development of Electronically Controlled Devices for Agnikarma

Not yet recruiting
Conditions
Diseases of the musculoskeletal system and connective tissue. Ayurveda Condition: VATAJASULAH,
Registration Number
CTRI/2024/10/075468
Lead Sponsor
DR S R Rajasthan Ayurved University Jodhpur
Brief Summary

Agnikarma is one and best among the Anu shastra and para-surgical procedure mentioned in various Ayurvedic texts. And is known for the last option in the disease which are not cured by herbal medicines, surgical intervention and Kshara (alkali).

In Ayurveda, different Acharyas defined and explained broadly about Agnikarma. Acharya Charaka,Sushruta and Vagbhatta explained different types, mode of application and procedure. Acharya Sushruta described in Sushruta Samhita, Sutra sthana in chapter Agnikarma is best among the variously explained therapeutic measures as Agnikarma, Shastra karma and Kshara karma.

Agnikarma is best as:

1. There is no recurrence of diseases.

2. Cures the disease completely from base.

3. The disease which are not cured by other measures can be cured.

We hypothesise that the Agni Karma procedure can be made at least twice as faster, more accurate, efficient & cost effective using our device rather than traditional methods of applying Agni Karma. There is also a possibility of reaching to a broader scope of work than just pain relief and the device can be targeted to cure various other ailments which work on the principle of cauterisation.

**Single-Arm Study:**

- This design can be used in the **early stages** to assess the efficacy, safety, and precision of **electronically controlled Agnikarma**. All patients undergo the new device-based treatment, and their outcomes are evaluated without comparison to another group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • •Patients with conditions traditionally treated by Agnikarma, such as joint pain, arthritis, sciatica, muscular spasms.
  • •Individuals with chronic pain unresponsive to other therapies, suitable for heat-based treatments.
  • •Participants aged between 18 to 65 years.
  • •Patients with stable conditions like diabetes or hypertension, without severe heat sensitivity or skin disorders.
  • •Individuals who provide informed consent and agree to follow-up assessments.
  • •Patients willing to undergo Agnikarma with electronically controlled devices.
  • •Ayurvedic practitioners trained in traditional Agnikarma, willing to adopt electronically controlled methods.
Exclusion Criteria
  • •Patients with severe skin conditions, burns, infections, or heat intolerance.
  • •Pregnant or lactating women due to potential risks.
  • •Patients with uncontrolled chronic illnesses like cardiac disease, advanced diabetes, or those with compromised immune systems; individuals on anticoagulant therapy.
  • •Subjects with severe psychiatric disorders or cognitive impairments affecting consent or protocol adherence.
  • •Individuals with a history of adverse reactions to Agnikarma.
  • •Patients unwilling to participate in electronically controlled Agnikarma or follow research protocols.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Data generation on Effectiveness and safety of electronically controlled Agnikarma DeviceWeekly
Secondary Outcome Measures
NameTimeMethod
oAssess the time efficiency, ease of use, and consistency of electronically controlled Agnikarma devices versus traditional methods.oConduct a cost-benefit analysis to determine if the new technology offers improved outcomes and value over time.

Trial Locations

Locations (1)

Sanjeevani Ayurveda Hospital DSRRAU JODHPUR

🇮🇳

Jodhpur, RAJASTHAN, India

Sanjeevani Ayurveda Hospital DSRRAU JODHPUR
🇮🇳Jodhpur, RAJASTHAN, India
Dr sanjay srivastava
Principal investigator
09414410383
sanjayphyayu@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.